SHENZHEN, China, December 4, 2012 /PRNewswire/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will hold its 2012 annual general meeting of record at the Company's Hong Kong office (Room 2813, Convention Plaza Office Tower, 1 Harbour Road, Wanchai, Hong Kong) at 10:30 a.m. on December 28, 2012 Beijing/Hong Kong Time (9:30 p.m. on December 27, 2012 U.S. Eastern Time). The shareholder record date is December 3, 2012.
Mindray has filed its annual report on Form 20-F, including its audited financial statements for the fiscal year ended December 31, 2011, with the U.S. Securities and Exchange Commission (the "SEC"). Mindray's Form 20-F and proxy materials can be accessed on the Investor Relations section of the Company's website at http://ir.mindray.com and on the SEC's website at http://www.sec.gov. Shareholders may request a hard copy of the complete audited financial statements on 20-F free of charge by contacting ir@mindray.com.
About Mindray
Mindray is a leading developer, manufacturer and marketer of medical devices worldwide. We maintain our global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China, we supply through our worldwide distribution network a broad range of products across three primary business segments, namely patient monitoring and life support, in-vitro diagnostic, and medical imaging systems. For more information, please visit: www.mindray.com
For investor and media inquiries, please contact:
In the U.S:
Hoki Luk
Western Bridge, LLC
Tel: +1-646-808-9150
Email: hoki.luk@westernbridgegroup.com
In China:
Cathy Gao
Mindray Medical International Limited
Tel: +86-755-8188-8023
Email: cathy.gao@mindray.com
